JAKARTA, INDONESIA--(Marketwire - Oct 31, 2012) - Moments ago, DividendSeeker.net introduced new coverage of Merck & Company, Inc. (NYSE: MRK) and Sanofi (NYSE: SNY). Full outlook, analysis and consensus opinion is available to readers via the links below.
The consistent delivery of accurate analyses relies solely on two factors, namely: market awareness and industry insight. Recent market drivers include a rise in new home sales to 5.7% in September to an annualized pace of 389,000 units, slightly stronger than market expectations for an increase to 385,000, recent confirmation of continued monetary stimulus and an unchanged FOMC policy and recent moderation of existing home sales in the US to 4.75 million annualized units in September 2012 from 4.83 million reported in the previous month. When it comes to discovering the right edge at the right time, all these factors play into effect. For a deeper understanding of the mechanics behind these events and how it can affect your portfolio, please refer to our email newsletter delivered to your inbox.
Dividend Seeker is releasing new coverage on Merck & Company, Inc. for its current position within the consumer durables sector. Merck & Co., Inc. (Merck) is a global health care company that delivers health solutions through its prescription medicines, vaccines, biologic therapies, animal health, and consumer care products, which it markets directly and through its joint ventures. A copy of this report featuring Merck & Company, Inc. (NYSE: MRK) is available at: www.DividendSeeker.net/r/forbes/430d_MRK.
Dividend Seeker has released research on Sanofi for its changing role within the consumer durables sector. Sanofi SA, formerly Sanofi-Aventis, is a global and diversified healthcare company. The Company discovers, develops and distributes therapeutic solutions focused on patients' needs. Sanofi focuses on the field of healthcare with six growth platforms: diabetes solutions, human vaccines, innovative drugs, consumer healthcare, emerging markets and animal health. To access the full research report on Sanofi (NYSE: SNY) we welcome investors to visit: www.DividendSeeker.net/r/forbes/29ea_SNY.
More About Dividend Seeker
For those looking to grow their portfolio and increase their net worth, Dividend Seeker is the right choice. Simplify your due diligence process and access investing tools and tips to head-start your investments. Join the community, subscribe to our newsletter and begin to experience the power of information. The more relevant data you have, the more opportunities you discover.